Clinical, genetic and pathological heterogeneity of frontotemporal dementia: A review

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 82, Issue 5, 2011, Pages 476-486

  Seelaar, Harro ^a   Rohrer, Jonathan D ^b   Pijnenburg, Yolande A L ^c   Fox, Nick C ^b   Van Swieten, John C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROGRANULIN; TAR DNA BINDING PROTEIN; TAU PROTEIN;

ABNORMAL BEHAVIOR; AMYOTROPHIC LATERAL SCLEROSIS; BLUNTED AFFECT; BRAIN ATROPHY; CEREBROSPINAL FLUID ANALYSIS; CHMP2B GENE; CHROMOSOME 9P; CLINICAL FEATURE; CLINICAL PRACTICE; DISEASE COURSE; EMOTIONAL DISORDER; EMOTIONALITY; FAMILY STUDY; FRONTOTEMPORAL DEMENTIA; FUS GENE; GENE; GENE MUTATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GEOGRAPHIC DISTRIBUTION; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; IMMUNOHISTOCHEMISTRY; INCIDENCE; METABOLIC DISORDER; MORPHOMETRICS; MOTOR NEURON DISEASE; NEUROIMAGING; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERSONALITY DISORDER; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; REVIEW; SOCIAL COGNITION; TARDP GENE; VCP GENE;

EID: 79953883507     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2010.212225     Document Type: Review

References (211)

1. Anon. Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. J Neurol Neurosurg Psychiatry 1994; 57: 416-18.
2. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998; 51: 1546-54.
3. McKhann GM, Albert MS, Grossman M, et al. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol 2001; 58: 1803-9. (Pubitemid 33044246)
4. Ratnavalli E, Brayne C, Dawson K, et al. The prevalence of frontotemporal dementia. Neurology 2002; 58: 1615-21. (Pubitemid 34602891)
5. Harvey RJ, Skelton-Robinson M, Rossor MN. The prevalence and causes of dementia in people under the age of 65 years. J Neurol Neurosurg Psychiatry 2003; 74: 1206-9.
6. Pick A. Ü ber die Beziehungen der senilen Hirnatropie zur Aphasie. Pragen Medizinischen Wochenschrift 1892; 17: 165-7.
7. Alzheimer A. Ü ber eigenartige Krankheitsfälle des späteren Alters. Zbl Ges Neurol Psych 1911; 4: 356-85.
8. Kertesz A, McMonagle P, Blair M, et al. The evolution and pathology of frontotemporal dementia. Brain 2005; 128: 1996-2005.
9. Seelaar H, Kamphorst W, Rosso SM, et al. Distinct genetic forms of frontotemporal dementia. Neurology 2008; 71: 1220-6.
10. Chow TW, Miller BL, Hayashi VN, et al. Inheritance of frontotemporal dementia. Arch Neurol 1999; 56: 817-22. (Pubitemid 29318907)
11. Goldman JS, Farmer JM, Wood EM, et al. Comparison of family histories in FTLD subtypes and related tauopathies. Neurology 2005; 65: 1817-19.
12. Hutton M, Lendon CL, Rizzu P, et al. Association of missense and 59-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998; 393: 702-5.
13. Baker M, Mackenzie IR, Pickering-Brown SM, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 2006; 442: 916-19. (Pubitemid 44285946)
14. q21. Nature 2006; 442: 920-4. (Pubitemid 44285947)
15. Sampathu DM, Neumann M, Kwong LK, et al. Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies. Am J Pathol 2006; 169: 1343-52. (Pubitemid 351194368)
16. Mackenzie IR, Baborie A, Pickering-Brown S, et al. Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype. Acta Neuropathol (Berl) 2006; 112: 539-49. (Pubitemid 44550678)
17. Cairns NJ, Bigio EH, Mackenzie IR, et al. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol (Berl) 2007; 114: 5-22. (Pubitemid 47029055)
18. Mackenzie IR, Neumann M, Bigio EH, et al. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol 2010; 119: 1-4.
19. Neumann M, Rademakers R, Roeber S, et al. A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain 2009; 132: 2922-31.
20. Borroni B, Alberici A, Grassi M, et al. Is frontotemporal lobar degeneration a rare disorder? Evidence from a preliminary study in Brescia County, Italy. J Alzheimers Dis 2010; 19: 11-6.
21. Rosso SM, Donker Kaat L, Baks T, et al. Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a populationbased study. Brain 2003; 126: 2016-22. (Pubitemid 37059441)
22. Brun A. Frontal lobe degeneration of non-Alzheimer type. I. Neuropathology. Arch Gerontol Geriatr 1987; 6: 193-208. (Pubitemid 17140253)
23. Ikeda M, Ishikawa T, Tanabe H. Epidemiology of frontotemporal lobar degeneration. Dementia Geriatr Cogn Disord 2004; 17: 265-8. (Pubitemid 38721138)
24. Gislason TB, Sjö gren M, Larsson L, et al. The prevalence of frontal variant frontotemporal dementia and the frontal lobe syndrome in a population based sample of 85 year olds. J Neurol Neurosurg Psychiatry 2003; 74: 867-71. (Pubitemid 36782985)
25. Knopman DS, Petersen RC, Edland SD, et al. The incidence of frontotemporal lobar degeneration in Rochester, Minnesota, 1990 through 1994. Neurology 2004; 62: 506-8. (Pubitemid 38200874)
26. Mercy L, Hodges JR, Dawson K, et al. Incidence of early-onset dementias in Cambridgeshire, United Kingdom. Neurology 2008; 71: 1496-9.
27. Hou CE, Yaffe K, Perez-Stable EJ, et al. Frequency of dementia etiologies in four ethnic groups. Dementia Geriatr Cogn Disord 2006; 22: 42-7.
28. Hodges JR, Davies R, Xuereb J, et al. Survival in frontotemporal dementia. Neurology 2003; 61: 349-54. (Pubitemid 36975964)
29. Johnson JK, Diehl J, Mendez MF, et al. Frontotemporal lobar degeneration: demographic characteristics of 353 patients. Arch Neurol 2005; 62: 925-30. (Pubitemid 40973454)
30. Le Ber I, Guedj E, Gabelle A, et al. Demographic, neurological and behavioural characteristics and brain perfusion SPECT in frontal variant of frontotemporal dementia. Brain 2006; 129: 3051-65. (Pubitemid 44684525)
31. Bathgate D, Snowden JS, Varma A, et al. Behaviour in frontotemporal dementia, Alzheimer's disease and vascular dementia. Acta Neurol Scand 2001; 103: 367-78. (Pubitemid 32531137)
32. Snowden JS, Bathgate D, Varma A, et al. Distinct behavioural profiles in frontotemporal dementia and semantic dementia. J Neurol Neurosurg Psychiatry 2001; 70: 323-32. (Pubitemid 32250888)
33. Snowden JS, Neary D, Mann DMA. Fronto-Temporal Lobar Degeneration: Fronto- Temporal Dementia, Progressive Aphasia, Semantic Dementia. London: Churchill- Livingstone, 1996.
34. Zamboni G, Huey ED, Krueger F, et al. Apathy and disinhibition in frontotemporal dementia: Insights into their neural correlates. Neurology 2008; 71: 736-42.
35. McMurtray AM, Chen AK, Shapira JS, et al. Variations in regional SPECT hypoperfusion and clinical features in frontotemporal dementia. Neurology 2006; 66: 517-22. (Pubitemid 43739879)
36. Peters F, Perani D, Herholz K, et al. Orbitofrontal dysfunction related to both apathy and disinhibition in frontotemporal dementia. Dementia Geriatric Cogn Disord 2006; 21: 373-9. (Pubitemid 43735682)
37. Woolley JD, Gorno-Tempini ML, Seeley WW, et al. Binge eating is associated with right orbitofrontal-insular-striatal atrophy in frontotemporal dementia. Neurology 2007; 69: 1424-33. (Pubitemid 47511464)
38. Huey ED, Goveia EN, Paviol S, et al. Executive dysfunction in frontotemporal dementia and corticobasal syndrome. Neurology 2009; 72: 453-9.
39. Bozeat S, Gregory CA, Ralph MA, et al. Which neuropsychiatric and behavioural features distinguish frontal and temporal variants of frontotemporal dementia from Alzheimer's disease? J Neurol Neurosurg Psychiatry 2000; 69: 178-86. (Pubitemid 30466021)
40. Miller BL, Ikonte C, Ponton M, et al. A study of the Lund-Manchester research criteria for frontotemporal dementia: clinical and single-photon emission CT correlations. Neurology 1997; 48: 937-42.
41. Marra C, Quaranta D, Zinno M, et al. Clusters of cognitive and behavioral disorders clearly distinguish primary progressive aphasia from frontal lobe dementia, and Alzheimer's disease. Dementia Geriatr Cogn Disord 2007; 24: 317-26. (Pubitemid 350036687)
42. Chow TW, Binns MA, Cummings JL, et al. Apathy symptom profile and behavioral associations in frontotemporal dementia vs dementia of Alzheimer type. Arch Neurol 2009; 66: 888-93.
43. Davies RR, Kipps CM, Mitchell J, et al. Progression in frontotemporal dementia: identifying a benign behavioral variant by magnetic resonance imaging. Arch Neurol 2006; 63: 1627-31. (Pubitemid 44748807)
44. Kipps CM, Nestor PJ, Acosta-Cabronero J, et al. Understanding social dysfunction in the behavioural variant of frontotemporal dementia: the role of emotion and sarcasm processing. Brain 2009; 132: 592-603.
45. Kipps CM, Nestor PJ, Fryer TD, et al. Behavioural variant frontotemporal dementia: not all it seems? Neurocase 2007; 13: 237-47. (Pubitemid 350153953)
46. Rosen HJ, Hartikainen KM, Jagust W, et al. Utility of clinical criteria in differentiating frontotemporal lobar degeneration (FTLD) from AD. Neurology 2002; 58: 1608-15. (Pubitemid 34602890)
47. Knopman DS, Boeve BF, Parisi JE, et al. Antemortem diagnosis of frontotemporal lobar degeneration. Ann Neurol 2005; 57: 480-8. (Pubitemid 40471156)
48. Forman MS, Farmer J, Johnson JK, et al. Frontotemporal dementia: clinicopathological correlations. Ann Neurol 2006; 59: 952-62. (Pubitemid 43830927)
49. Alladi S, Xuereb J, Bak T, et al. Focal cortical presentations of Alzheimer's disease. Brain 2007; 130: 2636-45. (Pubitemid 47511719)
50. Mendez MF, Shapira JS, McMurtray A, et al. Accuracy of the clinical evaluation for frontotemporal dementia. Arch Neurol 2007; 64: 830-5. (Pubitemid 46919837)
51. Rascovsky K, Hodges JR, Kipps CM, et al. Diagnostic criteria for the behavioral variant of frontotemporal dementia (bvFTD): current limitations and future directions. Alzheimer Dis Assoc Disord 2007; 21: S14-18. (Pubitemid 350307439)
52. Gorno-Tempini ML, Dronkers NF, Rankin KP, et al. Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol 2004; 55: 335-46. (Pubitemid 38269585)
53. Rosen HJ, Allison SC, Ogar JM, et al. Behavioral features in semantic dementia vs other forms of progressive aphasias. Neurology 2006; 67: 1752-6. (Pubitemid 44900748)
54. Gorno-Tempini ML, Brambati SM, Ginex V, et al. The logopenic/phonological variant of primary progressive aphasia. Neurology 2008; 71: 1227-34.
55. Rohrer JD, Crutch SJ, Warrington EK, et al. Progranulin-associated primary progressive aphasia: a distinct phenotype? Neuropsychologia 2010; 48: 288-97.
56. Davies RR, Hodges JR, Kril JJ, et al. The pathological basis of semantic dementia. Brain 2005; 128: 1984-95. (Pubitemid 41253266)
57. Grossman M. Primary progressive aphasia: clinicopathological correlations. Nat Rev Neurol 2010; 6: 88-97.
58. Mesulam M, Wicklund A, Johnson N, et al. Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia. Ann Neurol 2008; 63: 709-19. (Pubitemid 351945530)
59. Deramecourt V, Lebert F, Debachy B, et al. Prediction of pathology in primary progressive language and speech disorders. Neurology 2010; 74: 42-9.
60. Hu WT, McMillan C, Libon D, et al. Multimodal predictors for Alzheimer disease in nonfluent primary progressive aphasia. Neurology 2010; 75: 595-602.
61. Amici S, Gorno-Tempini ML, Ogar JM, et al. An overview on primary progressive aphasia and its variants. Behav Neurol 2006; 17: 77-87. (Pubitemid 44078630)
62. Brambati SM, Ogar J, Neuhaus J, et al. Reading disorders in primary progressive aphasia: a behavioral and neuroimaging study. Neuropsychologia 2009; 47: 1893-900.
63. Rohrer JD, Ridgway GR, Crutch SJ, et al. Progressive logopenic/ phonological aphasia: erosion of the language network. Neuroimage 2010; 49: 984-93.
64. Wilson SM, Henry ML, Besbris M, et al. Connected speech production in three variants of primary progressive aphasia. Brain 2010; 133: 2069-88.
65. Seelaar H, Schelhaas HJ, Azmani A, et al. TDP-43 pathology in familial frontotemporal dementia and motor neuron disease without Progranulin mutations. Brain 2007; 130: 1375-85. (Pubitemid 47355944)
66. Lomen-Hoerth C, Anderson T, Miller B. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology 2002; 59: 1077-9.
67. Chan D, Anderson V, Pijnenburg Y, et al. The clinical profile of right temporal lobe atrophy. Brain 2009; 132: 1287-98.
68. Josephs KA, Whitwell JL, Knopman DS, et al. Two distinct subtypes of right temporal variant frontotemporal dementia. Neurology 2009; 73: 1443-50.
69. Gregory CA, Hodges JR. Clinical features of frontal lobe dementia in comparison to Alzheimer's disease. J Neural Transm 1996; 47: 103-23. (Pubitemid 26275592)
70. Diehl-Schmid J, Pohl C, Perneczky R, et al. Behavioral disturbances in the course of frontotemporal dementia. Dementia Geriatr Cogn Disord 2006; 22: 352-7. (Pubitemid 44651451)
71. Hodges JR, Patterson K, Ward R, et al. The differentiation of semantic dementia and frontal lobe dementia (temporal and frontal variants of frontotemporal dementia) from early Alzheimer's disease: a comparative neuropsychological study. Neuropsychology 1999; 13: 31-40. (Pubitemid 29066435)
72. Kramer JH, Jurik J, Sha SJ, et al. Distinctive neuropsychological patterns in frontotemporal dementia, semantic dementia, and Alzheimer disease. Cogn Behav Neurol 2003; 16: 211-18. (Pubitemid 37517826)
73. Libon DJ, Xie SX, Wang X, et al. Neuropsychological decline in frontotemporal lobar degeneration: a longitudinal analysis. Neuropsychology 2009; 23: 337-46.
74. Wittenberg D, Possin KL, Rascovsky K, et al. The early neuropsychological and behavioral characteristics of frontotemporal dementia. Neuropsychol Rev 2008; 18: 91-102.
75. Snowden JS, Gibbons ZC, Blackshaw A, et al. Social cognition in frontotemporal dementia and Huntington's disease. Neuropsychologia 2003; 41: 688-701. (Pubitemid 36184602)
76. Rogers TT, Ivanoiu A, Patterson K, et al. Semantic memory in Alzheimer's disease and the frontotemporal dementias: a longitudinal study of 236 patients. Neuropsychology 2006; 20: 319-35. (Pubitemid 43886867)
77. Rascovsky K, Salmon DP, Hansen LA, et al. Disparate letter and semantic category fluency deficits in autopsy-confirmed frontotemporal dementia and Alzheimer's disease. Neuropsychology 2007; 21: 20-30. (Pubitemid 46066204)
78. Libon DJ, McMillan C, Gunawardena D, et al. Neurocognitive contributions to verbal fluency deficits in frontotemporal lobar degeneration. Neurology 2009; 73: 535-42.
79. Hodges JR, Davies RR, Xuereb JH, et al. Clinicopathological correlates in frontotemporal dementia. Ann Neurol 2004; 56: 399-406. (Pubitemid 39166559)
80. van Swieten JC, Heutink P. Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia. Lancet Neurol 2008; 7: 965-74.
81. Hornberger M, Piguet O, Graham AJ, et al. How preserved is episodic memory in behavioral variant frontotemporal dementia? Neurology 2010; 74: 472-9.
82. Nedjam Z, Devouche E, Dalla Barba G. Confabulation, but not executive dysfunction discriminate AD from frontotemporal dementia. Eur J Neurol 2004; 11: 728-33. (Pubitemid 39556752)
83. Hutchinson AD, Mathias JL. Neuropsychological deficits in frontotemporal dementia and Alzheimer's disease: a meta-analytic review. J Neurol Neurosurg Psychiatry 2007; 78: 917-28. (Pubitemid 47310825)
84. Collette F, Amieva H, Adam S, et al. Comparison of inhibitory functioning in mild Alzheimer's disease and frontotemporal dementia. Cortex 2007; 43: 866-74. (Pubitemid 47520451)
85. Lough S, Kipps CM, Treise C, et al. Social reasoning, emotion and empathy in frontotemporal dementia. Neuropsychologia 2006; 44: 950-8.
86. Rosen HJ, Wilson MR, Schauer GF, et al. Neuroanatomical correlates of impaired recognition of emotion in dementia. Neuropsychologia 2006; 44: 365-73. (Pubitemid 41821898)
87. Lavenu I, Pasquier F. Perception of emotion on faces in frontotemporal dementia and Alzheimer's disease: a longitudinal study. Dementia Geriatr Cogn Disord 2005; 19: 37-41. (Pubitemid 39664187)
88. Fernandez-Duque D, Black SE. Impaired recognition of negative facial emotions in patients with frontotemporal dementia. Neuropsychologia 2005; 43: 1673-87. (Pubitemid 40961688)
89. Keane J, Calder AJ, Hodges JR, et al. Face and emotion processing in frontal variant frontotemporal dementia. Neuropsychologia 2002; 40: 655-65. (Pubitemid 34037048)
90. Kipps CM, Mioshi E, Hodges JR. Emotion, social functioning and activities of daily living in frontotemporal dementia. Neurocase 2009; 15: 182-9.
91. Mendez MF, McMurtray A, Licht E, et al. The scale for emotional blunting in patients with frontotemporal dementia. Neurocase 2006; 12: 242-6. (Pubitemid 44473410)
92. Broe M, Hodges JR, Schofield E, et al. Staging disease severity in pathologically confirmed cases of frontotemporal dementia. Neurology 2003; 60: 1005-11. (Pubitemid 36348937)
93. Eslinger PJ, Moore P, Troiani V, et al. Oops! Resolving social dilemmas in frontotemporal dementia. J Neurol Neurosurg Psychiatry 2007; 78: 457-60. (Pubitemid 46662890)
94. Adenzato M, Cavallo M, Enrici I. Theory of mind ability in the behavioural variant of frontotemporal dementia: an analysis of the neural, cognitive, and social levels. Neuropsychologia 2010; 48: 2-12.
95. Gregory C, Lough S, Stone V, et al. Theory of mind in patients with frontal variant frontotemporal dementia and Alzheimer's disease: theoretical and practical implications. Brain 2002; 125: 752-64. (Pubitemid 34279771)
96. Rankin KP, Kramer JH, Miller BL. Patterns of cognitive and emotional empathy in frontotemporal lobar degeneration. Cogn Behav Neurol 2005; 18: 28-36. (Pubitemid 40381367)
97. Lavenu I, Pasquier F, Lebert F, et al. Perception of emotion in frontotemporal dementia and Alzheimer disease. Alzheimer Dis Assoc Disord 1999; 13: 96-101. (Pubitemid 29486193)
98. Sturm VE, Rosen HJ, Allison S, et al. Self-conscious emotion deficits in frontotemporal lobar degeneration. Brain 2006; 129: 2508-16. (Pubitemid 44522134)
99. Sturm VE, Ascher EA, Miller BL, et al. Diminished self-conscious motional responding in frontotemporal lobar degeneration patients. Emotion 2008; 8: 861-9.
100. Rohrer JD, Warren JD, Barnes J, et al. Mapping the progression of progranulinassociated frontotemporal lobar degeneration. Nat Clin Pract Neurol 2008; 4: 455-60.
101. Seeley WW, Crawford R, Rascovsky K, et al. Frontal paralimbic network atrophy in very mild behavioral variant frontotemporal dementia. Arch Neurol 2008; 65: 249-55. (Pubitemid 351240789)
102. Schroeter ML, Raczka K, Neumann J, et al. Neural networks in frontotemporal dementiaea meta-analysis. Neurobiol Aging 2008; 29: 418-26. (Pubitemid 351215583)
103. Seelaar H, Klijnsma KY, de Koning I, et al. Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration. J Neurol 2010; 257: 747-53.
104. Josephs KA, Whitwell JL, Parisi JE, et al. Caudate atrophy on MRI is a characteristic feature of FTLD-FUS. Eur J Neurol 2010; 17: 969-75.
105. Rohrer JD, Ridgway GR, Modat M, et al. The clinical and neuroanatomical phenotype of FUS-associated frontotemporal lobar degeneration. J Neurol Neurosurg Psychiatry. Published Online First: 16 July 2010.
106. Rohrer JD, Ridgway GR, Modat M, et al. Distinct profiles of brain atrophy in frontotemporal lobar degeneration caused by progranulin and tau mutations. Neuroimage 2010; 53: 1070-6.
107. Whitwell JL, Jack CR Jr, Boeve BF, et al. Voxel-based morphometry patterns of atrophy in FTLD with mutations in MAPT or PGRN. Neurology 2009; 72: 813-20.
108. Cruchaga C, Fernandez-Seara MA, Seijo-Martinez M, et al. Cortical atrophy and language network reorganization associated with a novel progranulin mutation. Cereb Cortex 2009; 19: 1751-60.
109. Whitwell JL, Jack CR Jr, Boeve BF, et al. Atrophy patterns in IVS10+16, IVS10+3, N279K, S305N, P301L, and V337M MAPT mutations. Neurology 2009; 73: 1058-65.
110. Whitwell JL, Przybelski SA, Weigand SD, et al. Distinct anatomical subtypes of the behavioural variant of frontotemporal dementia: a cluster analysis study. Brain 2009; 132: 2932-46.
111. Mummery CJ, Patterson K, Wise RJ, et al. Disrupted temporal lobe connections in semantic dementia. Brain 1999; 122: 61-73. (Pubitemid 29046273)
112. Mummery CJ, Patterson K, Price CJ, et al. A voxel-based morphometry study of semantic dementia: relationship between temporal lobe atrophy and semantic memory. Ann Neurol 2000; 47: 36-45. (Pubitemid 30033648)
113. Chan D, Fox NC, Scahill RI, et al. Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease. Ann Neurol 2001; 49: 433-42. (Pubitemid 32281327)
114. Galton CJ, Patterson K, Graham K, et al. Differing patterns of temporal atrophy in Alzheimer's disease and semantic dementia. Neurology 2001; 57: 216-25. (Pubitemid 32667354)
115. Rohrer JD, Warren JD, Modat M, et al. Patterns of cortical thinning in the language variants of frontotemporal lobar degeneration. Neurology 2009; 72: 1562-9.
116. Rohrer JD, McNaught E, Foster J, et al. Tracking progression in frontotemporal lobar degeneration: serial MRI in semantic dementia. Neurology 2008; 71: 1445-51.
117. Brambati SM, Rankin KP, Narvid J, et al. Atrophy progression in semantic dementia with asymmetric temporal involvement: a tensor-based morphometry study. Neurobiology Aging 2009; 30: 103-11.
118. Pereira JM, Williams GB, Acosta-Cabronero J, et al. Atrophy patterns in histologic vs clinical groupings of frontotemporal lobar degeneration. Neurology 2009; 72: 1653-60.
119. Ogar JM, Dronkers NF, Brambati SM, et al. Progressive nonfluent aphasia and its characteristic motor speech deficits. Alzheimer Dis Assoc Disord 2007; 21: S23-30. (Pubitemid 350307441)
120. Nestor PJ, Graham NL, Fryer TD, et al. Progressive non-fluent aphasia is associated with hypometabolism centred on the left anterior insula. Brain 2003; 126: 2406-18. (Pubitemid 37314431)
121. Looi JC, Lindberg O, Zandbelt BB, et al. Caudate nucleus volumes in frontotemporal lobar degeneration: differential atrophy in subtypes. Am J Neuroradiol 2008; 29: 1537-43.
122. Josephs KA, Duffy JR, Strand EA, et al. Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain 2006; 129: 1385-98. (Pubitemid 43999372)
123. Rohrer JD, Paviour D, Bronstein AM, et al. Progressive supranuclear palsy syndrome presenting as progressive nonfluent aphasia: a neuropsychological and neuroimaging analysis. Mov Disord 2010; 25: 179-88.
124. Lehmann M, Rohrer JD, Clarkson MJ, et al. Reduced cortical thickness in the posterior cingulate gyrus is characteristic of both typical and atypical Alzheimer's disease. J Alzheimers Dis 2010; 20: 587-98.
125. Whitwell JL, Jack CR Jr, Przybelski SA, et al. Temporoparietal atrophy: a marker of AD pathology independent of clinical diagnosis. Neurobiol Aging. Published Online First: 13 November 2009.
126. Migliaccio R, Agosta F, Rascovsky K, et al. Clinical syndromes associated with posterior atrophy: early age at onset AD spectrum. Neurology 2009; 73: 1571-8.
127. Davies RR, Scahill VL, Graham A, et al. Development of an MRI rating scale for multiple brain regions: comparison with volumetrics and with voxel-based morphometry. Neuroradiology 2009; 51: 491-503.
128. Kloppel S, Stonnington CM, Chu C, et al. Automatic classification of MR scans in Alzheimer's disease. Brain 2008; 131: 681-9. (Pubitemid 351294712)
129. Avants BB, Cook PA, Ungar L, et al. Dementia induces correlated reductions in white matter integrity and cortical thickness: a multivariate neuroimaging study with sparse canonical correlation analysis. Neuroimage 2010; 50: 1004-16.
130. Hu WT, Wang Z, Lee VM-Y, et al. Distinct cerebral perfusion patterns in FTLD and AD. Neurology 2010; 75: 881-8.
131. Rabinovici GD, Furst AJ, O'Neil JP, et al. 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration. Neurology 2007; 68: 1205-12. (Pubitemid 46608468)
132. Seeley WW, Crawford RK, Zhou J, et al. Neurodegenerative diseases target largescale human brain networks. Neuron 2009; 62: 42-52.
133. Zhou J, Greicius MD, Gennatas ED, et al. Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer's disease. Brain 2010; 133: 1352-67.
134. Seeley WW, Carlin DA, Allman JM, et al. Early frontotemporal dementia targets neurons unique to apes and humans. Ann Neurol 2006; 60: 660-7. (Pubitemid 46048483)
135. Verwey NA, Kester MI, van der Flier WM, et al. Additional value of CSF amyloidbeta 40 levels in the differentiation between FTLD and control subjects. J Alzheimers Dis 2010; 20: 445-52.
136. Coppola G, Karydas A, Rademakers R, et al. Gene expression study on peripheral blood identifies progranulin mutations. Ann Neurol 2008; 64: 92-6.
137. Finch N, Baker M, Crook R, et al. Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members. Brain 2009; 132: 583-91.
138. Ghidoni R, Benussi L, Glionna M, et al. Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration. Neurology 2008; 71: 1235-9.
139. Sleegers K, Brouwers N, Van Damme P, et al. Serum biomarker for progranulinassociated frontotemporal lobar degeneration. Ann Neurol 2009; 65: 603-9.
140. Carecchio M, Fenoglio C, De Riz M, et al. Progranulin plasma levels as potential biomarker for the identification of GRN deletion carriers. A case with atypical onset as clinical amnestic Mild Cognitive Impairment converted to Alzheimer's disease. J Neurol Sciences 2009; 287: 291-3.
141. Steinacker P, Hendrich C, Sperfeld AD, et al. TDP-43 in cerebrospinal fluid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Arch Neurol 2008; 65: 1481-7.
142. Foulds PG, Davidson Y, Mishra M, et al. Plasma phosphorylated-TDP-43 protein levels correlate with brain pathology in frontotemporal lobar degeneration. Acta Neuropathol 2009; 118: 647-58.
143. Hu WT, Chen-Plotkin A, Arnold SE, et al. Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease. Acta Neuropathol 2010; 120: 385-99.
144. Hu WT, Chen-Plotkin A, Grossman M, et al. Novel CSF biomarkers for frontotemporal lobar degeneration. Neurology Published Online First: November 3 2010. doi: 10.1212/WNL.0b013-318200d78d.
145. Stevens M, van Duijn CM, Kamphorst W, et al. Familial aggregation in frontotemporal dementia. Neurology 1998; 50: 1541-5. (Pubitemid 28283216)
146. Rohrer JD, Guerreiro R, Vandrovcova J, et al. The heritability and genetics of frontotemporal lobar degeneration. Neurology 2009; 73: 1451-6.
147. Goedert M, Spillantini MG, Jakes R, et al. Multiple isoforms of human microtubuleassociated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 1989; 3: 519-26.
148. Goedert M, Spillantini MG, Potier MC, et al. Cloning and sequencing of the Cdna ncoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J 1989; 8: 393-9. (Pubitemid 19274956)
149. van Swieten J, Spillantini MG. Hereditary frontotemporal dementia caused by Tau gene mutations. Brain Pathol 2007; 17: 63-73.
150. Boeve BF, Hutton M. Refining frontotemporal dementia with parkinsonism linked to chromosome 17: introducing FTDP-17 (MAPT) and FTDP-17 (PGRN). Arch Neurol 2008; 65: 460-4. (Pubitemid 351549953)
151. Gass J, Cannon A, Mackenzie IR, et al. Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum Mol Genet 2006; 15: 2988-3001. (Pubitemid 44530703)
152. Le Ber I, van der Zee J, Hannequin D, et al. Progranulin null mutations in both sporadic and familial frontotemporal dementia. Hum Mutat 2007; 28: 846-55. (Pubitemid 47579934)
153. Pickering-Brown SM, Baker M, Gass J, et al. Mutations in progranulin explain atypical phenotypes with variants in MAPT. Brain 2006; 129: 3124-6. (Pubitemid 44684531)
154. Ahmed Z, Mackenzie IR, Hutton ML, et al. Progranulin in frontotemporal lobar degeneration and neuroinflammation. J Neuroinflammation 2007; 4: 7.
155. Mackenzie IR, Baker M, Pickering-Brown S, et al. The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene. Brain 2006; 129: 3081-90. (Pubitemid 44684527)
156. Mesulam M, Johnson N, Krefft TA, et al. Progranulin mutations in primary progressive aphasia: the PPA1 and PPA3 families. Arch Neurol 2007; 64: 43-7. (Pubitemid 46072422)
157. Le Ber I, Camuzat A, Hannequin D, et al. Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study. Brain 2008; 131: 732-46. (Pubitemid 351294727)
158. Benussi L, Binetti G, Sina E, et al. A novel deletion in progranulin gene is associated with FTDP-17 and CBS. Neurobiol Aging 2008; 29: 427-35. (Pubitemid 351215590)
159. Boeve BF, Baker M, Dickson DW, et al. Frontotemporal dementia and parkinsonism associated with the IVS1+1G-> A mutation in progranulin: a clinicopathologic study. Brain 2006; 129: 3103-14. (Pubitemid 44684529)
160. Josephs KA, Ahmed Z, Katsuse O, et al. Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations. J Neuropathol Exp Neurol 2007; 66: 142-51. (Pubitemid 46208735)
161. Kelley BJ, Haidar W, Boeve BF, et al. Prominent phenotypic variability associated with mutations in Progranulin. Neurobiol Aging 2009; 30: 739-51.
162. Rademakers R, Baker M, Gass J, et al. Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477Ce> T (Arg493X) mutation: an international initiative. Lancet Neurol 2007; 6: 857-68. (Pubitemid 47404986)
163. Beck J, Rohrer JD, Campbell T, et al. A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series. Brain 2008; 131: 706-20. (Pubitemid 351294713)
164. Masellis M, Momeni P, Meschino W, et al. Novel splicing mutation in the progranulin gene causing familial corticobasal syndrome. Brain 2006; 129: 3115-23. (Pubitemid 44684530)
165. Rohrer JD, Warren JD, Omar R, et al. Parietal lobe deficits in frontotemporal lobar degeneration caused by a mutation in the progranulin gene. Arch Neurol 2008; 65: 506-13. (Pubitemid 351549960)
166. Pickering-Brown SM, Rollinson S, Du Plessis D, et al. Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations. Brain 2008; 131: 721-31. (Pubitemid 351294717)
167. Mackenzie IR, Baker M, West G, et al. A family with tau-negative frontotemporal dementia and neuronal intranuclear inclusions linked to chromosome 17. Brain 2006; 129: 853-67.
168. Watts GD, Wymer J, Kovach MJ, et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosincontaining protein. Nat Genet 2004; 36: 377-81. (Pubitemid 38437260)
169. Skibinski G, Parkinson NJ, Brown JM, et al. Mutations in the endosomal ESCRTIIIcomplex subunit CHMP2B in frontotemporal dementia. Nat Genet 2005; 37: 806-8. (Pubitemid 41077105)
170. Benajiba L, Le Ber I, Camuzat A, et al. TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration. Ann Neurol 2009; 65: 470-3.
171. Borroni B, Bonvicini C, Alberici A, et al. Mutation within TARDBP leads to frontotemporal dementia without motor neuron disease. Human Mutat 2009; 30: E974-83.
172. Kimonis VE, Fulchiero E, Vesa J, et al. VCP disease associated with myopathy,Paget disease of bone and frontotemporal dementia: review of a unique disorder. Biochim Biophys Acta 2008; 1782: 744-8.
173. Gydesen S, Brown JM, Brun A, et al. Chromosome 3 linked frontotemporal dementia (FTD-3). Neurology 2002; 59: 1585-94. (Pubitemid 35387067)
174. Parkinson N, Ince PG, Smith MO, et al. ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B). Neurology 2006; 67: 1074-7. (Pubitemid 44454610)
175. Yokoseki A, Shiga A, Tan CF, et al. TDP-43 mutation in familial amyotrophic lateral sclerosis. Ann Neurol 2008; 63: 538-42. (Pubitemid 351614721)
176. Gitcho MA, Baloh RH, Chakraverty S, et al. TDP-43 A315T mutation in familial motor neuron disease. Ann Neurol 2008; 63: 535-8. (Pubitemid 351614720)
177. Sreedharan J, Blair IP, Tripathi VB, et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 2008; 319: 1668-72. (Pubitemid 351432505)
178. Daoud H, Valdmanis PN, Kabashi E, et al. Contribution of TARDBP mutations to sporadic amyotrophic lateral sclerosis. J Med Genet 2009; 46: 112-14.
179. Kabashi E, Valdmanis PN, Dion P, et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet 2008; 40: 572-4. (Pubitemid 351601218)
180. Kuhnlein P, Sperfeld AD, Vanmassenhove B, et al. Two German kindreds with familial amyotrophic lateral sclerosis due to TARDBP mutations. Arch Neurol 2008; 65: 1185-9.
181. Rutherford NJ, Zhang YJ, Baker M, et al. Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. PLoS Genet 2008; 4: e1000193.
182. Van Deerlin VM, Leverenz JB, Bekris LM, et al. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol 2008; 7: 409-16.
183. Vance C, Rogelj B, Hortobagyi T, et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 2009; 323: 1208-11.
184. Kwiatkowski TJ Jr, Bosco DA, Leclerc AL, et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 2009; 323: 1205-8.
185. Chio A, Restagno G, Brunetti M, et al. Two Italian kindreds with familial amyotrophic lateral sclerosis due to FUS mutation. Neurobiol Aging 2009; 30: 1272-5.
186. Groen EJ, van Es MA, van Vught PW, et al. FUS mutations in familial amyotrophic lateral sclerosis in The Netherlands. Arch Neurol 2010; 67: 224-30.
187. Van Langenhove T, van der Zee J, Sleegers K, et al. Genetic contribution of FUS to frontotemporal lobar degeneration. Neurology 2010; 74: 366-71.
188. Le Ber I, Camuzat A, Berger E, et al. Chromosome 9p-linked families with frontotemporal dementia associated with motor neuron disease. Neurology 2009; 72: 1669-76.
189. Vance C, Al-Chalabi A, Ruddy D, et al. Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2-21.3. Brain 2006; 129: 868-76.
190. Morita M, Al-Chalabi A, Andersen PM, et al. A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia. Neurology 2006; 66: 839-44. (Pubitemid 43739757)
191. Momeni P, Schymick J, Jain S, et al. Analysis of IFT74 as a candidate gene for chromosome 9p-linked ALS-FTD. BMC Neurol 2006; 6: 44.
192. Valdmanis PN, Dupre N, Bouchard JP, et al. Three families with amyotrophic lateral sclerosis and frontotemporal dementia with evidence of linkage to chromosome 9p. Arch Neurol 2007; 64: 240-5.
193. Luty AA, Kwok JB, Thompson EM, et al. Pedigree with frontotemporal lobar degenerationdmotor neuron disease and Tar DNA binding protein-43 positive neuropathology: genetic linkage to chromosome 9. BMC Neurol 2008; 8: 32.
194. Rademakers R, Eriksen JL, Baker M, et al. Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia. Hum Mol Genet 2008; 17: 3631-42.
195. Simon-Sanchez J, Seelaar H, Bochdanovits Z, et al. Variation at GRN 3'-UTR rs5848 is not associated with a risk of frontotemporal lobar degeneration in Dutch population. PloS One 2009; 4: e7494.
196. Rollinson S, Rohrer JD, van der Zee J. No association of PGRN 3'UTR rs5848 in frontotemporal lobar degeneration. Neurobiol Aging 2011; 32: 754-5.
197. Verpillat P, Camuzat A, Hannequin D, et al. Apolipoprotein E gene in frontotemporal dementia: an association study and meta-analysis. Eur J Hum Genet 2002; 10: 399-405.
198. Srinivasan R, Davidson Y, Gibbons L, et al. The apolipoprotein E epsilon4 allele selectively increases the risk of frontotemporal lobar degeneration in males. J Neurol Neurosurg Psychiatry 2006; 77: 154-8. (Pubitemid 43220833)
199. Rohrer JD, Mead S, Omar R, et al. Prion protein (PRNP) genotypes in frontotemporal lobar degeneration syndromes. Ann Neurol 2006; 60: 616; author reply 7. (Pubitemid 44871805)
200. Li X, Rowland LP, Mitsumoto H, et al. Prion protein codon 129 genotype prevalence is altered in primary progressive aphasia. Ann Neurol 2005; 58: 858-64. (Pubitemid 41748288)
201. Benussi L, Ghidoni R, Galimberti D, et al. The CST3 B haplotype is associated with frontotemporal lobar degeneration. Eur J Neurol 2010; 17: 143-6.
202. Rollinson S, Rizzu P, Sikkink S, et al. Ubiquitin associated protein 1 is a risk factor for frontotemporal lobar degeneration. Neurobiol Aging 2009; 30: 656-65.
203. Van Deerlin VM, Sleiman PMA, Martinez-Lage M, et al. Common genetic variants at 7p21 show strong association with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet 2010; 42: 234-9.
204. Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006; 314: 130-3. (Pubitemid 44547757)
205. Josephs KA, Lin WL, Ahmed Z, et al. Frontotemporal lobar degeneration with ubiquitin-positive, but TDP-43-negative inclusions. Acta Neuropathol 2008; 116: 159-67.
206. Mackenzie IR, Foti D, Woulfe J, et al. Atypical frontotemporal lobar degeneration with ubiquitin-positive, TDP-43-negative neuronal inclusions. Brain 2008; 131: 1282-93.
207. Roeber S, Mackenzie IR, Kretzschmar HA, et al. TDP-43-negative FTLD-U is a significant new clinico-pathological subtype of FTLD. Acta Neuropathol 2008; 116: 147-57.
208. Urwin H, Josephs KA, Rohrer JD, et al. FUS pathology defines the majority of tauand TDP-43-negative frontotemporal lobar degeneration. Acta Neuropathol 2010; 120: 33-41.
209. Neumann M, Roeber S, Kretzschmar HA, et al. Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease. Acta Neuropathol 2009; 118: 605-16.
210. Holm IE, Isaacs AM, Mackenzie IR. Absence of FUS-immunoreactive pathology in frontotemporal dementia linked to chromosome 3 (FTD-3) caused by mutation in the CHMP2B gene. Acta Neuropathol 2009; 118: 719-20.
211. Mioshi E, Hsieh S, Savage S, et al. Clinical staging and disease progression in frontotemporal dementia. Neurology 2010; 74: 1591-7.